Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effects
Fiche du document
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/jnci/85.23.1962
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/7693957
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0027-8874
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A110F417A08C6
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Therapy Granulocyte-colony stimulating factor G-CSF (Colony-stimulating factor) Tumours Neoplasms Treatments for diseases Medical treatment Therapy Treatment of diseases Progenitor cells Mother cells Colony-forming units (Cells) Marrow Medulla ossium People Man Humanity (Human beings) Human race Mankind Homo sapiens Humankind Humans Auditory system Drug therapy, Combination Combination chemotherapy Combination drug therapy Polychemotherapy Drug therapy Pharmacotherapy Stem cell transplantationCiter ce document
S. Leyvraz et al., « Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effects », Serveur académique Lausannois, ID : 10.1093/jnci/85.23.1962
